Literature DB >> 7535525

Erythropoietin induces tyrosine phosphorylation of the beta chain of the GM-CSF receptor.

Y Hanazono1, K Sasaki, H Nitta, Y Yazaki, H Hirai.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and erythropoietin (EPO) induce tyrosine phosphorylation of the GM-CSF receptor beta chain and the EPO receptor, respectively, although their receptors lack the tyrosine kinase activity. We have shown that EPO as well as GM-CSF induces tyrosine phosphorylation of the beta chain. Conversely, GM-CSF does not induce tyrosine phosphorylation of the EPO receptor. Tyrosine phosphorylation of the beta chain by stimulation with EPO is rapid and transient. EPO may trans-modulate a signaling pathway of GM-CSF by phosphorylating the beta chain of the GM-CSF receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535525     DOI: 10.1006/bbrc.1995.1442

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The receptor that tames the innate immune response.

Authors:  Michael Brines; Anthony Cerami
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

2.  Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.

Authors:  Melissa P Wu; Emanuela Gussoni
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

3.  The beta c component of the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin 3 (IL-3)/IL-5 receptor interacts with a hybrid GM-CSF/erythropoietin receptor to influence proliferation and beta-globin mRNA expression.

Authors:  P T Jubinsky; Y Shikama; A Laurie; D G Nathan; M Carroll; C A Sieff
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

4.  Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor.

Authors:  James L Miller; Timothy J Church; Dmitri Leonoudakis; Karen Lariosa-Willingham; Normand L Frigon; Connie S Tettenborn; Jeffrey R Spencer; Juha Punnonen
Journal:  Mol Pharmacol       Date:  2015-05-27       Impact factor: 4.436

5.  Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse.

Authors:  Tonia S Rex; Ying Wong; Kishore Kodali; Shayla Merry
Journal:  Exp Eye Res       Date:  2009-07-08       Impact factor: 3.467

Review 6.  Role of erythropoietin in the brain.

Authors:  Constance Tom Noguchi; Pundit Asavaritikrai; Ruifeng Teng; Yi Jia
Journal:  Crit Rev Oncol Hematol       Date:  2007-05-04       Impact factor: 6.312

7.  Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common beta chain in transgenic mice.

Authors:  R J D'Andrea; D Harrison-Findik; C M Butcher; J Finnie; P Blumbergs; P Bartley; M McCormack; K Jones; R Rowland; T J Gonda; M A Vadas
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

8.  Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation.

Authors:  Konrad Pazdrak; Travis W Young; Susan Stafford; Barbara Olszewska-Pazdrak; Christof Straub; Vitaliy Starosta; Allan Brasier; Alexander Kurosky
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

9.  Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration.

Authors:  Pasqualina Colella; Carolina Iodice; Umberto Di Vicino; Ida Annunziata; Enrico M Surace; Alberto Auricchio
Journal:  Hum Mol Genet       Date:  2011-03-19       Impact factor: 6.150

Review 10.  Erythropoietin Receptor/β Common Receptor: A Shining Light on Acute Kidney Injury Induced by Ischemia-Reperfusion.

Authors:  Yuanyuan Wu; Bin Yang
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.